Clinical Trials in Tennessee

Showing 5121-5140 of 20,239 trials

Gluten Technology and Education for Celiac Health

NCT06059716

The investigators propose to plan for a multi-center randomized controlled trial (M-RCT) to test the effectiveness of novel gluten detection technologies as an adjunct to telemedicine to manage celiac disease in newly diagnosed adults. If successful, the proposed intervention will improve mucosal recovery, promote a shift in current practice of celiac disease management toward long-term monitoring, and represent a significant step toward reducing the severe physical and psychological consequences of celiac disease.

Celiac Disease

Columbia University200 participantsStarted Oct 2024

Chicago, Illinois, United States • Boston, Massachusetts, United States • New York, New York, United States +1 more locations

Active Not RecruitingPhase 129 miles

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

NCT04603001

This is an open-label, multi-center Phase 1 study of LY3410738, an oral, covalent isocitrate dehydrogenase (IDH) inhibitor, in patients with IDH1 and/or IDH2-mutant advanced hematologic malignancies who may have received standard therapy

Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more

Eli Lilly and Company260 participantsStarted Nov 2020

Duarte, California, United States • Los Angeles, California, United States • Sacramento, California, United States +34 more locations

Gluten Technology and Education for Celiac Health

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Find Trials by Condition in Tennessee

A Study Evaluating Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy

BIG Study (Brain, Immune, and Gut Health Evaluation of Infants/Young Children Fed Infant Formula, and Later Supplemental Toddler Nutrition, With 5 Specific HMOs)

Intramyocardial Injection of Autologous UCB-MNC During Fontan Surgery for SRV Dependent CHD

Open Label Extension for 43USSA1812

Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma

LTFU for All Cell and Gene Therapy Studies

Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite

Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas

Adolescent Master Protocol

The Biomarkers in the Hyperbaric Oxygen Brain Injury Treatment Trial (BioHOBIT)

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures

Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer

1630GCC: Zydelig Maintenance in B-Cell Non-Hodgkin's Lymphoma After Autologous Stem Cell Transplantation

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

FS120 Phase 1/1b Study in Patients With Advanced Malignancies

Cough Reduction in IPF With Nalbuphine ER

Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics